Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Metabolic and Anti-Inflammatory Effects of Combined Ezetimibe and Simvastin Therapy, as Compared to Simvastatin Alone, in Patients With Chronic Proteinuric Nephropathy

NCT00861731 is registered in ClinicalTrials.gov with Azienda Ospedaliero Universitaria di Sassari as lead sponsor.

NCT NCT00861731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00861731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Metabolic and Anti-Inflammatory Effects of Combined Ezetimibe and Simvastin Therapy, as Compared to Simvastatin Alone, in Patients With Chronic Proteinuric Nephropathy
Lead sponsor
Azienda Ospedaliero Universitaria di Sassari
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2008
Completion date
July 31, 2009
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic nephropathy, hypercholesterolemia